MicroRNAs as Biomarker in Rheumatoid Arthritis: Pathogenesis to Clinical Relevance
Authors:
- MasihuddinMAMasihuddin
- Sayali MukherjeeSMSayali Mukherjee
- 22 December 2024
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 126 (2) , e30690
Abstract
MicroRNAs (miRNAs) have emerged as intricate players in rheumatoid arthritis (RA), holding promise as discerning biomarkers for diagnostic and prognostic purposes. The lack of sensitivity and specificity in current diagnostic techniques, such as rheumatoid factor (RF) and anti‐citrullinated protein antibodies (ACPA), causes diagnosis delays in RA. The miR‐146a and miR‐155 act in inflammatory cascades and reduce joint deterioration, and miR‐223 is paradoxical, acting differently in different illness scenarios. The microenvironment of RA is shaped by the complex modulation of gene expression and cytokine dynamics by miR‐126 and miR‐24. miRNAs serve as a promising candidate for precision medicine in the management of RA. There are obstacles encountered in validation, delivery optimization, and off‐target effect mitigation before miRNA‐based biomarkers may be applied in clinical settings. Machine learning (ML) and artificial intelligence (AI) have been used to integrate miRNA expression patterns with clinical data to greatly advance the treatment of RA. Because of the disease's inherent complexity and variability, these state‐of‐the‐art models provide accurate predictions regarding the onset, development, and response to treatment of RA. By using clinical information and miRNA expression data, ML algorithms are revolutionizing the treatment of RA by predicting the onset and course of the disease with remarkably high accuracy. The development of therapeutic modalities and miRNA profiling has great potential to transform the diagnosis, prognosis, and treatment of RA, providing fresh hope for better patient outcomes.Keywords
This publication has 63 references indexed in Scilit:
- Correction to: Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guideAnnals of Hematology, 2021
- Circulating miRNAs and tissue iron overload in transfusion-dependent β-thalassemia major: novel predictors and follow-up guideAnnals of Hematology, 2021
- Resveratrol protects human bronchial epithelial cells against nickel‐induced toxicity via suppressing p38 MAPK, NF‐κB signaling, and NLRP3 inflammasome activationEnvironmental Toxicology, 2020
- In vitro knock‐out of miR‐155 suppresses leukemic and HCV virus loads in pediatric HCV‐4–associated acute lymphoid leukemia: A promising target therapyJournal of Cellular Biochemistry, 2019
- NKCC1 promotes EMT‐like process in GBM via RhoA and Rac1 signaling pathwaysJournal of Cellular Physiology, 2018
- Selected cytokine pathways in rheumatoid arthritisSeminars in Immunopathology, 2017
- Current Physical Activity Is Independently Associated With Cortical Bone Size and Bone Strength in Elderly Swedish WomenJournal of Bone and Mineral Research, 2016
- Loss of Type I Collagen Telopeptide Lysyl Hydroxylation Causes Musculoskeletal Abnormalities in a Zebrafish Model of Bruck SyndromeJournal of Bone and Mineral Research, 2016
- MicroRNA‐451 Down‐Regulates Neutrophil Chemotaxis via p38 MAPKArthritis & Rheumatology, 2013
- The inhibitory effect of microRNA-146a expression on bone destruction in collagen-induced arthritisArthritis & Rheumatism, 2011